Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 142

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

854	NVLX Hot News:	stocklegend	04/09/2014 3:01:51 PM
853	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/09/2014 1:48:35 PM
852	NVLX That loud noise you hear coming from	stocklegend	04/09/2014 12:24:00 PM
851	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/09/2014 11:09:00 AM
850	NVLX Pancreatic Cancer Cures?	stocklegend	04/09/2014 10:14:41 AM
849	NVLX news:	stocklegend	04/09/2014 8:57:39 AM
848	News looking great!	stocklegend	04/08/2014 3:51:16 PM
847	NVLX Nuvilex's proprietary Cell-in-a-Box	stocklegend	04/08/2014 3:05:29 PM
846	NVLX "Dr. Rabe is Chairman of Medical Marijuana	stocklegend	04/08/2014 2:16:27 PM
845	Dr. Rabe's presentation, "Targeted	stocklegend	04/08/2014 1:12:47 PM
844	NVLX The conference, hosted by Americans for Safe	stocklegend	04/08/2014 11:15:18 AM
843	Medical Marijuana Sciences' Dr. Mark L. Rabe	stocklegend	04/08/2014 10:06:52 AM
842	NVLX news:	stocklegend	04/08/2014 9:37:28 AM
841	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/07/2014 4:08:18 PM
840	NVLX Hot News:	stocklegend	04/07/2014 2:54:04 PM
839	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/07/2014 1:44:11 PM
838	NVLX That loud noise you hear coming from	stocklegend	04/07/2014 11:46:28 AM
837	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/07/2014 10:13:12 AM
836	NVLX Pancreatic Cancer Cures?	stocklegend	04/07/2014 9:20:38 AM
835	NVLX Pancreatic Cancer Cures?	stocklegend	04/04/2014 1:55:45 PM
834	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/04/2014 1:06:50 PM
833	NVLX Hot News:	stocklegend	04/04/2014 11:56:20 AM
832	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/04/2014 11:04:02 AM
831	NVLX That loud noise you hear coming from	stocklegend	04/04/2014 10:17:36 AM
830	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/04/2014 9:13:44 AM
829	NVLX Translational Drug Development or TD2 will	stocklegend	04/03/2014 2:04:45 PM
828	NVLX Dr. Daniel Von Hoff, the world's leading	stocklegend	04/03/2014 1:10:23 PM
827	NVLX That loud noise you hear coming from	stocklegend	04/03/2014 11:15:31 AM
826	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/03/2014 10:05:15 AM
825	NVLX Pancreatic Cancer Cures?	stocklegend	04/03/2014 9:16:18 AM
824	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/02/2014 1:57:20 PM
823	NVLX Hot News:	stocklegend	04/02/2014 12:32:50 PM
822	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/02/2014 11:53:13 AM
821	NVLX About Nuvilex: Nuvilex is a clinical-stage	stocklegend	04/02/2014 10:51:16 AM
820	NVLX A clinical-stage international	stocklegend	04/02/2014 10:00:40 AM
819	NVLX Pancreatic Cancer Cures?	stocklegend	04/02/2014 9:03:46 AM
818	Dr. Von Hoff is THE LEADING FIGURE in pancreatic	Tandrel	04/02/2014 9:03:17 AM
817	NVLX "We are honored that TD2 and Dr. Von Hoff	stocklegend	04/01/2014 2:25:58 PM
816	NVLX The PCRT, an affiliate of TD2, has the	stocklegend	04/01/2014 1:20:46 PM
815	NVLX Dr. Von Hoff is the one who developed	stocklegend	04/01/2014 12:14:36 PM
814	NVLX "Our Pancreatic Cancer Research Team (PCRT)	stocklegend	04/01/2014 11:29:49 AM
813	NVLX "The Nuvilex team presents us with a new	stocklegend	04/01/2014 10:15:37 AM
812	NVLX NEWS:	stocklegend	04/01/2014 9:35:17 AM
811	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	04/01/2014 9:08:03 AM
810	$NVLX With live-cell encapsulation, depending on	Tandrel	04/01/2014 8:27:23 AM
809	$NVLX ~ Here's a simple Nuvilex chart:	Tandrel	04/01/2014 8:25:12 AM
808	$NVLX's live-cell encapsulation technology is a	Tandrel	04/01/2014 8:23:22 AM
807	$NVLX Investors Confidently Back Nuvilex's	stocklegend	03/31/2014 1:57:24 PM
806	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/31/2014 1:47:30 PM
805	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/31/2014 12:48:10 PM

Newer

Older

Recent Articles

• EngageSmart Investors Alert: Key Dates for Class Action Suit
• Disney Settles $43M Gender Pay Discrimination Lawsuit
• Securities Fraud Class Action Filed Against Dentsply Sirona Inc.
• Oil Prices Maintain Stability Amid Ceasefire Discussions and OPEC+ Meeting
• China's Industrial Profit Decline Signals Economic Challenges
• Sri Lanka Implements New Monetary Policy for Economic Recovery
• KKR's Interest Spurs Rise in Seven & i Holdings Shares
• Key Insights on Amazon, CrowdStrike, Autodesk, Dell, and Tesla Stocks
• BrilliA Inc Sets its Initial Public Offering Price at $4.00
• Important Update for Match Group Shareholders on Legal Action
• Brazil Potash Sets Price for Initial Public Offering of Shares
• Securities Fraud Class Action Launched Against Rentokil Initial
• RBNZ Implements Significant Rate Cut to Stimulate Recovery
• S.F. Holding Enters Hong Kong Market with Stable Debut
• Mynaric Investors Alert: Legal Options for Shareholder Claims
• Warren Challenges Trump's Funding Tactics and Ethical Standards
• Investigation into Iris Energy: What Investors Need to Know
• Acadia Healthcare Faces Class Action Lawsuit Amid Concerns
• Investors Alert: Join the Toronto-Dominion Bank Class Action
• ASML Holding Investors Alert: Class Action Lawsuit Update
• Visa Investors Alert: Legal Actions and Opportunities for Recovery
• Investors Notified of Class Action Against Hasbro: Important Updates
• Chipotle Investors Can Take Action in Class Action Lawsuit
• Lilium N.V. Faces Legal Scrutiny Amid Financial Challenges
• Key Legal Developments for Celsius Holdings Investors
• Investigation Launched for Toronto-Dominion Bank Shareholders
• PACS Group Investors Urged to Act Amid Class Action Lawsuits
• Important Update for Zeta Global Investors Facing Losses
• Jim Cramer Advocates for Bitcoin and Ethereum as Safe Assets
• Impact of Proposed Tariffs on Energy and Agricultural Commodities
• ARK ETF Adjusts Investment Strategy with Key Stock Moves
• Australia's Inflation Landscape: A Steady Shift in Core Rates
• Global Currency Trends Amid US Economic Outlook: Insights
• New Zealand Central Bank Lowers Cash Rate for Economic Boost
• China's Response to Trump's Tariff Threats Amid Fentanyl Crisis
• Hyundai Motor Receives Positive Outlook from Morgan Stanley
• Investors of China Evergrande Demand Action from Authorities
• Celsius Holdings Faces Legal Challenges Over PepsiCo Deal
• Investigation by Faruqi & Faruqi into ASML Holding after Losses
• Exploring the Future of the Peptide Synthesis Market Growth
• Investors Unite: Leading the Class Action Against Rentokil
• Investors Urged to Explore Rights in Edwards Lifesciences Case
• Investigation Underway for WM Technology Investors Due to Misrepresentation
• Investor Alert: Legal Action Regarding TMC Investigated
• Forecasting Growth in the Personalized Medicines Sector
• Argenta Silver Corp. Updates on Meeting Materials for Shareholders
• Australia's CPI Trends: Inflation Insights Amid Subsidy Support
• ASP Isotopes Faces Scrutiny After Controversial Report
• Wall Street Is Spot On About 2024 Earnings Predictions
• ATRenew Celebrates First Profit Amid Growing Trade-In Trend